Rx IP Update
Rx IP Update provides timely reports and commentary on developments in Canadian intellectual property law that are of particular interest to the pharmaceutical industry, including summaries of new cases before the courts. If you have any comments on the content or presentation of Rx IP Update, or if you would like more information on a specific issue, please do not hesitate to contact Gunars Gaikis or Nancy Pei (editor).
